Publications Similar Clinical Improvement Rates Among Biologic Drug Classes in Crohn’s Disease: Systematic Review and Meta-Regression Citation Jurij Hanžel, Rocio Sedano, Jenny Jeyarajah, Guangyong Zou, Stefanie C McFarlane, Christopher Ma, Vipul Jairath. Similar Clinical Improvement Rates Among Biologic Drug Classes in Crohn's Disease: Systematic Review and Meta-Regression. Inflamm Bowel Dis. 2022 Feb 15;izac018. DOI: 10.1093/ibd/izac018. Online ahead of print. PMID: 35166778 DOI: 10.1093/ibd/izac018. Abstract Plain language summary We conducted a systematic review and metaregression of pivotal Crohn’s disease trials to evaluate the rates of change in Crohn’s Disease Activity Index scores in patients receiving biologic treatments. The speed of clinical improvement was similar among biologic drug classes. Tags Biological Products, Crohn's Disease, Drug Therapy, therapeutic use Read More